A multi-omic biomarker signature in pre-treatment rectal tumours stratifies patients with different pathological responses to neoadjuvant treatment.

Laura E Kane, Croí E Buckley, Rebecca M O'Brien, Meghana S Menon, Aisling B Heeran, Xiaofei Yin, Timothy S Nugent, Noel E Donlon, John V Reynolds, Adnan Hafeez, Diarmuid S O'Ríordáin, Robert A Hannon, Paul Neary, Reza Kalbassi, Brian J Mehigan